Cardioselective beta-blockers do not appear to increase the rate of exacerbations in patients with chronic obstructive pulmonary disease. Cardioselective beta-blockers do not appear to increase the ...

The question of whether to alter beta-blocker therapy in patients with asthma has been reviewed extensively in the medical literature. [1,2,3,4,5] Cardioselective (beta-1) beta-blockers are ...

Oct. 26, 2004 (Seattle) -- Physicians are often reluctant to use beta-blockers in patients whose congestive heart failure (CHF) is complicated by chronic obstructive pulmonary disease (COPD), but that ...

One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans who ...

Please provide your email address to receive an email when new articles are posted on . Nonselective systemic β-blocker intake showed a clinically relevant association and a borderline significant ...

Patients with HF, including those with concomitant COPD, benefit from treatment with BBs, and these drugs should be used to improve outcomes in these patients. However, not only are BBs not prescribed ...

Human heart, computer artwork. Landiolol is an ultra-short acting, cardioselective, beta-1 adrenoceptor blocker designed to reduce heart rate with a minimal effect over cardiac contractility. The New ...

Researchers discuss optimal approaches to treating hypertension in patients with COPD, with a given patient’s underlying lung function and any coexisting conditions highlighted as important factors of ...